Cargando…
Oncolytic virotherapy in hepato‐bilio‐pancreatic cancer: The key to breaking the log jam?
Traditional therapies have limited efficacy in hepatocellular carcinoma, pancreatic cancer, and biliary tract cancer, especially for advanced and refractory cancers. Through a deeper understanding of antitumor immunity and the tumor microenvironment, novel immunotherapies are becoming available for...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196045/ https://www.ncbi.nlm.nih.gov/pubmed/32130786 http://dx.doi.org/10.1002/cam4.2949 |